Schwazze, Formerly Operating as Medicine Man Technologies, Inc., to Participate in Two Upcoming Virtual Investor Conferences
Schwazze, formerly operating as Medicine Man Technologies, Inc. (OTCQX:SHWZ) (“Schwazze” or “the Company"), announced today that it will be participating in two upcoming virtual investor conferences.
Benzinga Virtual Cannabis Capital Conference
Mr. Justin Dye, Chairman and Chief Executive Officer of Schwazze, will be discussing the Company's recent updates during the virtual Benzinga Cannabis Capital Conference on Monday, June 1, 2020 at 3:30 p.m. ET. Mr. Dye and the Schwazze leadership team will also be hosting investor meetings during the conference.
Oppenheimer 20th Annual Virtual Consumer Growth and E-Commerce Conference
The Schwazze leadership team will be hosting investor meetings as part of Oppenheimer’s 20th Annual Virtual Consumer Growth and E-Commerce Conference on Tuesday and Wednesday, June 16-17, 2020.
For more information about Schwazze, please visit https://www.Schwazze.com/.
Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its vision to become one of the nation’s largest vertically integrated cannabis holding companies by revenue. Upon the completion of its announced acquisitions, its portfolio will consist of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.
This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control and cannot be predicted or quantified. Consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product candidates on a commercial scale on our own or in collaboration with third parties; (ii) difficulties in obtaining financing on commercially reasonable terms; (iii) changes in the size and nature of our competition; (iv) loss of one or more key executives or scientists; and (v) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.
Medicine Man Technologies Aktie jetzt über den Testsieger (Finanztest 11/2020) handeln, ab 0 € auf Smartbroker.de